Propanc Biopharma, Inc.: Form 8-K, filed Jul 5, 2016
Filed with the SEC on Jul 5, 2016 and accepted by EDGAR at Jul 5, 2016, 17:14 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001144204-16-111538. Last ingested by Listed: Nov 14, 2026, 18:42 ET. Listed shows no prices and gives no investment advice.